BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 8655665)

  • 1. Color doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist.
    Ernst H; Hahn EG; Balzer T; Schlief R; Heyder N
    J Clin Ultrasound; 1996 Jan; 24(1):31-5. PubMed ID: 8655665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Native and signal-enhanced power Doppler sonography for characterization of liver lesions].
    Strunk H; Stuckmann G; Fröhlich E; Textor J; Wilhelm K; Hortling N; Remig J
    Rofo; 1998 Apr; 168(4):344-51. PubMed ID: 9589096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Color Doppler sonography of hepatic tumors with a galactose-based contrast agent: correlation with angiographic findings.
    Fujimoto M; Moriyasu F; Nishikawa K; Nada T; Okuma M
    AJR Am J Roentgenol; 1994 Nov; 163(5):1099-104. PubMed ID: 7976882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascularization patterns in focal liver lesions: comparison of plain and signal-enhanced amplitude-modulated color duplex ultrasonography].
    Hosten N; Steger W; Bechstein WO; Zendel WJ; Venz S; Lemke AJ; Weber S; Vogl TJ; Felix R
    Rofo; 1997 Jun; 166(6):507-13. PubMed ID: 9273003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions.
    Hosten N; Puls R; Lemke AJ; Steger W; Zendel W; Zwicker C; Felix R
    J Clin Ultrasound; 1999; 27(3):107-15. PubMed ID: 10064407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of an ultrasound contrast agent (levovist) in color Doppler imaging of liver neoplasms.
    Jiang Y; Dai Q; Liu J; Zhang J; Chang X; Cai S; Tan L
    Chin Med Sci J; 1999 Sep; 14(3):167-9. PubMed ID: 12903818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced color flows in hepatic tumors.
    Yang CC; Chen CH; Yeh YH
    Hepatogastroenterology; 2002; 49(48):1506-9. PubMed ID: 12397719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doppler and color Doppler ultrasound diagnosis in differentiation of focal liver lesions].
    Paintner A; Bayer C; Böttcher B; Wenk H; Swobodnik W
    Bildgebung; 1996 Mar; 63(1):22-6. PubMed ID: 8653004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stimulated acoustic emissions with the ultrasound contrast medium levovist: a clinically useful contrast effect with liver-specific properties].
    Albrecht T; Blomley MJ; Heckemann RA; Cosgrove DO; Jayaram V; Butler-Barnes J; Eckersley RJ; Hoffmann CW; Bauer A
    Rofo; 2000 Jan; 172(1):61-7. PubMed ID: 10719465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood flow patterns in focal liver lesions at microbubble-enhanced US.
    Brannigan M; Burns PN; Wilson SR
    Radiographics; 2004; 24(4):921-35. PubMed ID: 15256618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
    Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
    Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
    Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
    Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse inversion sonography in the early phase of the sonographic contrast agent Levovist: differentiation between benign and malignant focal liver lesions.
    von Herbay A; Vogt C; Häussinger D
    J Ultrasound Med; 2002 Nov; 21(11):1191-200. PubMed ID: 12418760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal hepatic lesions: contrast-enhancement patterns at pulse-inversion harmonic US using a microbubble contrast agent.
    Kim EA; Yoon KH; Lee YH; Kim HW; Juhng SK; Won JJ
    Korean J Radiol; 2003; 4(4):224-33. PubMed ID: 14726639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of superb microvascular imaging in focal liver lesions.
    He MN; Lv K; Jiang YX; Jiang TA
    World J Gastroenterol; 2017 Nov; 23(43):7765-7775. PubMed ID: 29209117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions.
    Furuse J; Nagase M; Ishii H; Yoshino M
    Br J Radiol; 2003 Jun; 76(906):385-92. PubMed ID: 12814924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist).
    Uggowitzer M; Kugler C; Gröll R; Mischinger HJ; Stacher R; Fickert P; Weiglein A
    Br J Radiol; 1998 Oct; 71(850):1026-32. PubMed ID: 10211062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection: preliminary results.
    Bertolotto M; Dalla Palma L; Quaia E; Locatelli M
    Eur Radiol; 2000; 10(9):1369-76. PubMed ID: 10997422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.